Genoa Pharmaceuticals — a biopharmaceutical company working on treatments for respiratory diseases — was operating under the radar just last week.… Read More
Seattle-based biotech juggernaut Juno Therapeutics delivered mixed results in its 2017 quarter one earnings report Thursday — the first financial report… Read More
Seattle biotech company Alpine Immune Sciences is raising $17 million as part of a merger with Nivalis, a publicly-traded pharmaceutical firm… Read More
Seattle-based M3 Biotechnology announced it has received a $1.4 million investment from the Alzheimer’s Drug Discovery Foundation, allowing it to begin… Read More
Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million… Read More
Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got… Read More
Sound Pharmaceuticals, a Seattle startup developing therapies and preventative treatments for hearing loss, is in the midst of a $30 million… Read More